The global synthetic stem cell market size is expected to grow from USD 14 million in 2023 to USD 37 million by 2028, at a CAGR of 22.5% during the forecast period. The major factors driving the growth of the synthetic stem cells market are ethical concerns regarding embryonic stem cells and the risk of tumor formation and immune rejection of natural stem cells.
Currently, synthetic stem cell technology is co-developed and patented by North Carolina State University (NCSU) (US) and Zhengzhou University (China).
To know about the assumptions considered for the study download the pdf brochure
In line with the rising importance of stem cell, researcher Ke Cheng, an associate professor at North Carolina State University, and his research partner Dr. Thomas Caranasos of the University of North Carolina School of Medicine created a protocol to harvest the healing factors secreted by the heart stem cells and encapsulate them synthetically. This offers a breakthrough in cardiac treatment using these artificial stem cells. The study was conducted in animal models and is expected to require five more years to be conducted on humans. This ‘platform technology’ is expected to be a breakthrough in the field of stem cell therapy in the coming years.
Related Reports:
Synthetic Stem Cells Market by Application (Cardiovascular Disease, Neurological Disorders, Other Applications (Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders)), Region (North America (US, Canada}, Europe, APAC, RoW) - Global Forecast to 2028
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE